The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
暂无分享,去创建一个
[1] Christian Gluud,et al. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? , 2003, JAMA.
[2] E. Ritz,et al. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy , 2003, Diabetologia.
[3] C. Gross,et al. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. , 2003, JAMA.
[4] L. Kjaergard,et al. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ , 2002, BMJ : British Medical Journal.
[5] V. Fuster,et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: Risk Assessment in Persons With Diabetes , 2002, Circulation.
[6] E. Peterson,et al. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. , 2002, JAMA.
[7] E. Antman,et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat , 2002, Circulation.
[8] T. Nickelsen,et al. [Data validity and coverage in the Danish National Health Registry. A literature review]. , 2001, Ugeskrift for laeger.
[9] B. Gersh,et al. Unrecognized Myocardial Infarction , 2001, Annals of Internal Medicine.
[10] D. Moher,et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.
[11] null Not Available. World Medical Association Declaration of Helsinki , 2000 .
[12] WMADo Helsinki. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. , 2000, Nursing ethics.
[13] Douglas G Altman,et al. Blinding in clinical trials and other studies , 2000, BMJ : British Medical Journal.
[14] P. Kligfield,et al. Postoperative Prophylactic Administration of &bgr;-Adrenergic Blockers in Patients at Risk for Myocardial Ischemia , 2000, Anesthesia and analgesia.
[15] V. Fuster,et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. , 2000, Circulation.
[16] Jeroen J. Bax,et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.
[17] L. Goldman,et al. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). , 1999, Anesthesiology.
[18] Farris K. Timimi,et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. , 1999, Anesthesia and analgesia.
[19] A. Gelb,et al. Myocardial Infarction after Noncardiac Surgery , 1998, Anesthesiology.
[20] A. Wallace,et al. Prophylactic Atenolol Reduces Postoperative Myocardial Ischemia , 1998, Anesthesiology.
[21] A. Wallace,et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.
[22] J. Lerman. Study design in clinical research: sample size estimation and power analysis , 1996, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[23] R. Nesto,et al. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. , 1992, Journal of the American College of Cardiology.
[24] T. Riles,et al. Silent myocardial ischemia monitoring predicts late as well as perioperative cardiac events in patients undergoing vascular surgery. , 1992, Journal of vascular surgery.
[25] L. Way,et al. Long-term cardiac prognosis following noncardiac surgery , 1992 .
[26] W. Browner,et al. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. , 1992, JAMA.
[27] E. Cook,et al. Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery. , 1992, JAMA.
[28] W. Browner,et al. In-hospital and long-term mortality in male veterans following noncardiac surgery. The Study of Perioperative Ischemia Research Group. , 1992, JAMA.
[29] W. Browner,et al. In-Hospital and Long-term Mortality in Male Veterans Following Noncardiac Surgery , 1992 .
[30] D. Mangano,et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery--II: Incidence and severity during the 1st week after surgery. The Study of Perioperative Ischemia (SPI) Research Group. , 1991, Journal of the American College of Cardiology.
[31] W. Browner,et al. Association of Perioperative Myocardial Ischemia with Cardiac Morbidity and Mortality in Men Undergoing Noncardiac Surgery , 1990 .
[32] D. Mangano. Perioperative cardiac morbidity , 1990, Anesthesiology.
[33] C. Coley,et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery , 1989 .
[34] P. Coriat,et al. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous diltiazem: a randomized trial versus placebo. , 1987, Anesthesiology.
[35] P. Coriat. Intravenous nitroglycerin dosage to prevent intraoperative myocardial ischemia during noncardiac surgery. , 1986, Anesthesiology.
[36] D. Kereiakes. Myocardial infarction in the diabetic patient , 1985, Clinical cardiology.
[37] I. R. Thomson,et al. Failure of Intravenous Nitroglycerin to Prevent Intraoperative Myocardial Ischemia during Fentanyl–Pancuronium Anesthesia , 1984, Anesthesiology.
[38] P. Schnohr,et al. Electrocardiographic findings and their association with mortality in the Copenhagen City Heart Study. , 1981, European heart journal.
[39] J. vonKnorring,et al. Postoperative myocardial infarction: a prospective study in a risk group of surgical patients. , 1981, Surgery.
[40] D L McGee,et al. Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study , 1979, Diabetes Care.
[41] L Goldman,et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. , 1977, The New England journal of medicine.
[42] S. Dack. POSTOPERATIVE MYOCARDIAL INFARCTION. , 1963, The American journal of cardiology.
[43] C. Dahlöf,et al. Controlled-release metoprolol compared with atenolol in asthmatic patients: Interaction with terbutaline , 2004, European Journal of Clinical Pharmacology.
[44] J. Cruickshank. Beta-Blockers and Diabetes: The Bad Guys Come Good , 2002, Cardiovascular Drugs and Therapy.
[45] S. Kimmel,et al. Perioperative β-blocker withdrawal and mortality in vascular surgical patients , 2001 .